Effective polymer adjuvants for sustained delivery of protein subunit vaccines
Source abstract
Abstract
We have synthesized thermogelling cationic amphiphilic pentablock copolymers that have the potential to act as injectable vaccine carriers and adjuvants that can simultaneously provide sustained delivery and enhance the immunogenicity of released antigen. While these pentablock copolymers have shown efficacy in DNA delivery in past studies, the ability to deliver both DNA and protein for subunit vaccines using the same polymeric carrier can provide greater flexibility and efficacy. We demonstrate the ability of these pentablock copolymers, and the parent triblock Pluronic copolymers to slowly release structurally intact and antigenically stable protein antigens in vitro, create an antigen depot through long-term injection-site persistence and enhance the in vivo immune response to these antigens. We show release of the model protein antigen ovalbumin in vitro from the thermogelling block copolymers with the primary, secondary and tertiary structures of the released protein unchanged compared to the native protein, and its antigenicity preserved upon release. The block copolymers form a gel at physiological temperatures that serves as an antigenic depot and persists in vivo at the site of injection for over 50days. The pentablock copolymers show a significant fivefold enhancement in the immune response compared to soluble protein alone, even 6weeks after the administration, based on measurement of antibody titers. These results demonstrate the potential of these block copolymers hydrogels to persist for several weeks and sustain the release of antigen with minimal effects on protein stability and antigenicity; and their ability to be used simultaneously as a sustained delivery device as well as a subunit vaccine adjuvant platform.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Immunotherapy and Immune Responses · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (68)
Show source-provided references
1. Enhancing the immune response through next generation polymeric vaccine adjuvants10.1142/S2339547814300017 ↗
2. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs10.1016/S0168-3659(01)00276-0 ↗
3. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines10.1016/S0169-409X(98)00012-X ↗
4. Formulation aspects of biodegradable polymeric microspheres for antigen delivery10.1016/j.addr.2004.09.002 ↗
5. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery10.1016/S0168-3659(02)00009-3 ↗
6. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers10.1016/j.jconrel.2008.04.013 ↗
7. PH- and temperature-dependent phase behavior of a PEO–PPO–PEO-based pentablock copolymer in aqueous media10.1103/PhysRevE.78.021802 ↗
8. Pluronic® F127-based systemic vaccine delivery systems10.1016/j.vaccine.2003.11.064 ↗
9. Biodegradable block copolymers as injectable drug-delivery systems10.1038/42218 ↗
10. Drug release from pH-responsive thermogelling pentablock copolymers10.1002/jbm.a.30991 ↗
11. Adjuvants designed for veterinary and human vaccines10.1016/S0264-410X(00)00498-9 ↗
12. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses10.1038/nri1372 ↗
13. Synthesis and functionalization of virus-mimicking cationic block copolymers with pathogen-associated carbohydrates as potential vaccine adjuvants10.1039/c3ra47687a ↗
14. Vaccine adjuvants: putting innate immunity to work10.1016/j.immuni.2010.10.002 ↗
15. Amphiphilic polyanhydrides for protein stabilization and release10.1016/j.biomaterials.2006.08.047 ↗
16. The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres10.1080/02652040601033841 ↗
17. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens10.1016/j.addr.2004.09.003 ↗
18. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens10.1074/jbc.M500687200 ↗
19. T cells down-modulate peptide–MHC complexes on APCs in vivo10.1038/ni742 ↗
20. Immunity to viruses: learning from successful human vaccines10.1111/imr.12099 ↗
21. Protein stability in controlled-release systems10.1038/71875 ↗
22. Novel cationic pentablock copolymers as non-viral vectors for gene therapy10.1016/j.jconrel.2004.11.022 ↗
23. Investigation of in vitro biocompatibility of novel pentablock copolymers for gene delivery10.1002/jbm.a.30920 ↗
24. Novel pentablock copolymers for selective gene delivery to cancer cells10.1007/s11095-008-9813-y ↗
25. PLGA-based nanoparticles: an overview of biomedical applications10.1016/j.jconrel.2012.01.043 ↗
26. Novel atom transfer radical polymerization method to yield copper-free block copolymeric biomaterials10.1002/macp.201300034 ↗
27. The mechanism of selective transfection mediated by pentablock copolymers. Part II. Nuclear entry and endosomal escape10.1016/j.actbio.2010.11.033 ↗
28. Injectable self-assembled block copolymers for sustained gene and drug co-delivery: an in vitro study10.1016/j.ijpharm.2011.10.018 ↗
29. Synthesis and characterization of temperature and pH-responsive pentablock copolymers10.1016/j.polymer.2005.05.138 ↗
30. Stabilized copper(I) oxide nanoparticles catalyze azide–alkyne click reactions in water10.1002/adsc.201000206 ↗
31. Three-dimensional biochemical and biomechanical patterning of hydrogels for guiding cell behavior10.1002/adma.200600647 ↗
32. Gradient biomaterials for soft-to-hard interface tissue engineering10.1016/j.actbio.2011.01.011 ↗
33. Generation of porous poly(ethylene glycol) hydrogels by salt leaching10.1089/ten.tec.2009.0646 ↗
34. Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels10.1016/S0142-9612(98)00025-8 ↗
35. Fabrication of poly(ethylene glycol) hydrogel microstructures using photolithography10.1021/la010075w ↗
36. Dual-role self-assembling nanoplexes for efficient gene transfection and sustained gene delivery10.1016/j.biomaterials.2007.10.010 ↗
37. β-Sheet structure formation of proteins in solid state as revealed by circular dichroism spectroscopy10.1002/1097-0282(2001)62:1<15::AID-BIP30>3.0.CO;2-J ↗
38. Structure and properties of ovalbumin10.1016/S0378-4347(01)00108-6 ↗
39. Computational insights into processes underlying the amine-induced fluorescence quenching of a stimuli-responsive phenol-based hexameric foldamer host10.1021/jo500028t ↗
40. Adjuvants – a balance between toxicity and adjuvanticity10.1016/0264-410X(93)90190-9 ↗
41. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge10.1016/j.ijpharm.2003.10.038 ↗
42. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination10.1016/j.jconrel.2009.05.011 ↗
43. Vaccine adjuvants: current challenges and future approaches10.1002/jps.21523 ↗
44. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules10.1021/nn900715g ↗
45. A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection10.1016/j.jconrel.2008.07.025 ↗
46. Photopolymerized hydrogel carriers for live vaccine ballistic delivery10.1016/j.vaccine.2005.05.048 ↗
47. Atom transfer radical polymerization10.1021/cr940534g ↗
48. Immunomodulatory biomaterials10.1016/j.ijpharm.2008.06.030 ↗
49. Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines10.1016/j.tibtech.2011.02.004 ↗
50. Poly(d,l-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method – processing and formulation issues for enhanced entrapment efficiency10.1080/02652040400026442 ↗
51. Immune response with biodegradable nanospheres and alum: studies in rabbits using staphylococcal enterotoxin B-toxoid10.1080/026520400288454 ↗
52. Hydrogels for protein delivery10.1021/cr200157d ↗
53. Time spent by primary care practices on pediatric influenza vaccination visits: implications for universal influenza vaccination10.1001/archpedi.157.2.191 ↗
54. Thermosensitive sol–gel reversible hydrogels10.1016/S0169-409X(01)00242-3 ↗
55. Antigen persistence is required throughout the expansion phase of a CD4+ T cell response10.1084/jem.20042521 ↗
56. Innate immunity together with duration of antigen persistence regulate effector T cell induction10.4049/jimmunol.171.2.795 ↗
57. The effect of heparin on the gellation of Pluronic F-127 hydrogel10.1016/j.colsurfa.2005.10.060 ↗
58. DNA vaccines: immunology, application, and optimization10.1146/annurev.immunol.18.1.927 ↗
59. Immunological adjuvant effect of Glycyrrhiza uralensis saponins on the immune responses to ovalbumin in mice10.1016/j.vaccine.2005.10.040 ↗
60. Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses10.1002/jbm.b.32820 ↗
61. Controlled release microparticles for vaccine development10.1016/0264-410X(91)90295-H ↗
62. In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery10.1016/j.ejps.2010.07.004 ↗
63. Alginate hydrogels as biomaterials10.1002/mabi.200600069 ↗
64. Biodegradable thermosensitive injectable PEG–PCL–PEG hydrogel for bFGF antigen delivery to improve humoral immunity10.3109/08977190903159938 ↗
65. Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization10.1016/j.biomaterials.2011.11.068 ↗
66. ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoid10.1016/S0264-410X(01)00423-6 ↗
67. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines10.1038/nmat2784 ↗
68. Microparticles as vaccine adjuvants and delivery systems10.1586/14760584.2.2.269 ↗